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Abstract Verrucous carcinoma is a rare tumor that
presents in the head and neck with the most common sites
being the oral cavity and larynx. Fourteen cases of verru-
cous carcinoma of the temporal bone have been described
in literature; this study aims to examine treatment
outcomes and discuss the controversy surrounding post-
operative radiation. The study design included a literature
review along with individual case report in the setting of a
tertiary care medical center. Outcome analysis of all cases
of verrucous carcinoma of the temporal bone, which are
documented in the English literature, and presentation of a
single patient report including gross, histologic and radio-
logic analyses were performed. The longest recorded
survival for verrucous carcinoma of the temporal bone
occurs in patients treated with surgery alone. Poorer out-
comes for patients treated with adjuvant (chemo)radiation
may be due to more advanced stage of disease at the time
of treatment. Early reports of radiation leading to tumor
dedifferentiation or early recurrence are not supported by
more recent studies. Whether adjuvant radiation therapy is
indicated in verrucous carcinoma of the temporal bone
remains controversial.
Keywords Verrucous carcinoma  Temporal bone 
Adjuvant radiation
Introduction
Verrucous carcinoma is a rare variant of squamous cell
carcinoma that presents in the head and neck with the most
common sites being the oral cavity and larynx [1–8]. It is
so uncommon, in fact, that verrucous carcinoma composes
only 5% of tumors at these sites [2, 14]. It represents 1–4%
of laryngeal malignancies [9], and the most common lar-
yngeal subsite is the vocal cords. Other sites in the head
and neck have been reported, including the paranasal
sinuses [10], scalp [11], nasopharynx [12], and esophagus
[13]. This cancer also has been associated with tobacco
use, alcohol use, and poor oral hygiene.
Histologically, verrucous carcinoma is a wart-like lesion
and displays keratosis and parakeratosis [14]. The thick-
ened squamous epithelium gives it its characteristic church
spire appearance. Although its histology is seemingly
benign with ‘‘pushing’’ borders, it follows an insidious
clinical course with aggressive local invasion and lymph
node metastasis. The presence of submucous ﬁbrosis and
leukoplakia are associated with poor outcomes [15].
Verrucous carcinoma extremely rarely involves the
temporal bone, and only 14 cases have been reported in
literature [3, 16–24]. Because so few cases of verrucous
carcinoma involving the middle ear and temporal bone
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DOI 10.1007/s00405-010-1281-4have been described, there is no consensus on the best
course of treatment for these lesions. We discuss the out-
comes of patients described in each of these studies,
present an additional case of verrucous carcinoma of the
temporal bone with skull base invasion, and discuss the
treatment controversy surrounding adjuvant radiotherapy.
Materials and methods
Studies were identiﬁed by a search of the Pubmed elec-
tronic database for ‘verrucous’ and ‘temporal bone’, or
‘ear’. Only studies published in the English literature were
included. Ten case reports and series were identiﬁed,
including a total of 14 patients with verrucous carcinoma of
the temporal bone. Treatment modality, patient outcome
including time to disease-speciﬁc death, and previous
otologic surgery were recorded. Additional case report
information from the current study was added to these
results.
Results
Case report
A 51-year-old male presented with a 6-month history of a
growing right external auditory canal mass. He had asso-
ciated right-sided otalgia, subjective right-sided hearing
loss, and occasional right-sided tinnitus. Just before pre-
sentation, he developed a right otitis externa, which
improved with topical antibiotic ear drops and oral anti-
biotics. He denied any vertigo, headaches, or vision
changes.
The patient had a 40 pack-year smoking history and a
history of extensive intravenous drug use. Past medical
history was otherwise noncontributory. On examination,
the patient was found to have a fungating mass originating
from the posterolateral portion of the right external audi-
tory canal. He had no lymphadenopathy, and the facial
nerve was intact bilaterally.
CT of the temporal bone showed a right mastoid defect
and absence of the ossicles (Fig. 1). Soft tissue was present
in the mesotympanum and epitympanum. The residual
right sclerotic temporal bone was under-pneumatized and
completely opaciﬁed. MRI of the internal auditory canals
demonstrated complete opaciﬁcation of the right middle
ear cavity and right mastoid defect (Fig. 2). The mass
extended superiorly into the right middle cranial fossa
where it abutted the dura at the inferior aspect of the right
inferolateral temporal lobe. The mass also seemed to
invade the more lateral limb of the lateral semicircular
canal. No abnormalities of the bilateral internal auditory
canals or cerebellopontine angles were appreciated.
Biopsy of the right external auditory canal mass was
consistent with verrucous carcinoma. The patient under-
went right superﬁcial parotidectomy, mastoidectomy,
Fig. 1 Axial (a) and coronal
(b) CT scan of the temporal
bone demonstrating soft tissue
density with extension from the
right external auditory canal to
the right epitympanum,
mesotympanum, and
hypotympanum with dehiscence
of the overlying right tegmen
tympani and absence of the right
ossicular chain
Fig. 2 Axial T2-weighted MRI (a) on a 1.5 T MRI demonstrating a
soft tissue mass originating in the right external auditory canal and
middle ear with dehiscence of the right tegmen tympani. Coronal T1-
weighted MRI (b) showing extension superiorly into the right middle
cranial fossa where the mass abuts the dura at the inferior aspect of
the right inferolateral temporal lobe
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poral craniotomy for resection of this tumor. Because the
mass extended intracranially, the involved dura was
resected and repaired with rotated temporoparietal fascia.
Pathology again revealed verrucous carcinoma (Fig. 3). He
did not receive postoperative radiation. He continues to do
well postoperatively.
Literature analysis
We present the 15th patient in the English literature with
verrucous carcinoma of the temporal bone. Of the 14 cases
previously reviewed, information regarding treatment and
outcome is available in 12 (Table 1). Of the ﬁve patients
treated with surgery alone, two resulted in early disease-
speciﬁc death. Interestingly, Edelstein et al. [19] describe a
period of survival of 4–10 years in three of these patients.
Kletzker et al. [24] also describe a patient who was disease
free 3 years after surgery. Two patients were treated with
surgery and radiation therapy: one died soon after treat-
ment and the other did not have recorded follow-up. Three
patients were treated with surgery and chemoradiation; of
these two died soon after treatment and one was alive at
18 months.
Discussion
Verrucous carcinoma is most commonly diagnosed in the
oral cavity (55.9%) and the larynx (35.2%) [25] and has a
good prognosis when treated early with local excision [26].
As previously described, verrucous carcinoma is a benign-
appearing lesion with ‘‘pushing’’ borders, and the basement
membrane can appear to be intact [27]. This histology
often presents a diagnostic challenge, as the differential
diagnosis includes pseudoepitheliomatous hyperplasia,
squamous papilloma, keratosis, and verrucous hyperplasia
[28, 29]. In fact, a signiﬁcant number of cases require
multiple biopsies for deﬁnitive diagnosis [9], and coordi-
nation between the surgeon and pathologist is critical for
accurate and timely diagnosis [30].
Although early lesions are usually treated with local
excision, controversy remains regarding the optimal course
of treatment for more advanced lesions. It is generally
accepted that radiation is not as effective as surgery in the
initial treatment of verrucous carcinoma [31]; however, the
effectiveness of radiation used as adjuvant treatment
remains a topic of debate.
Traditionally, possible risks have been suggested to be
associated with adjuvant radiation therapy for verrucous
Fig. 3 Verrucous carcinoma showing marked exophytic growth with
keratinization, and a broad rounded rete extending deep into the
underlying collagen
Table 1 Patient treatment and
outcome in all cases and case
series published in the English
literature
Previous mastoidectomy on the
side of the verrucous carcinoma,
treatment modality, and length
of survival or time to disease-
speciﬁc death after treatment
were recorded
N/a studies without available
information, DSD disease-
speciﬁc death
Study Previous mastoidectomy Treatment Survival
Ferlito et al. [3] n/a n/a n/a
Pleat et al. [16] Yes Surgery 2 months to DSD
Woodson et al. [17] No Surgery ? xrt n/a
Proops et al. [18] Yes Surgery ? chemoxrt 18 months follow-up
Edelstein et al. [19] No Surgery 10 year follow-up
No Surgery 5 year follow-up
No Surgery 4 year follow-up
Yes Surgery ? chemoxrt 11 months to DSD
Yes Surgery ? chemo 1 year to DSD
Diengdoh et al. [20] No Surgery 6 months to DSD
Farrell and Dowe [21] Yes Surgery ? xrt 8 months to DSD
Hagiwara et al. [22] n/a n/a n/a
Aydogan et al. [23] Yes Surgery 26 months follow-up
Kletzker et al. [24] Yes Surgery 3 years follow-up
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123carcinoma, including increased rates of distant metastasis,
anaplastic transformation, and dedifferentiation of tumors.
Reports of anaplastic transformation and an increase in
nodal metastases come largely from earlier communica-
tions (prior to the early 1990s) [32–35]. More recent
reports have not conﬁrmed these results [3, 9, 23, 36, 37].
Maurizi et al. [38] raised a concern about early recurrence
as they found that in the treatment of 31 patients with
verrucous carcinoma of the larynx, radiation therapy in
addition to surgery was associated with an early recurrence
in two of seven patients treated with both modalities.
However, this study was limited by its small sample size. A
recent report suggests that dedifferentiation can occur not
only after radiation, but also before treatment and after
surgery alone [39].
In 1998, the Mayo Clinic reviewed 52 cases of laryngeal
verrucous carcinoma and concluded that radiotherapy can
be used effectively as an adjunct to surgical resection to
preserve laryngeal function [40]. Only one of four patients
in this series treated with radiotherapy to control residual
disease developed a recurrence, and none showed dedif-
ferentiation or distant metastasis after radiation treatment.
Although more current reports do not indicate that
adjuvant radiation incurs increased risk of dedifferentia-
tion, there are very few reports that describe treated cases
of verrucous carcinoma of the temporal bone [3, 16–24].
We present the 15th patient with this disease described in
the English literature. Aydogan et al. [23] most recently
reviewed cases of verrucous carcinoma, but did not include
the data of Kletzker et al. [24]. The majority of patients
described in the literature had a history of chronic otitis
media with aural drainage, and 7 of 14 patients had a
history of previous mastoid surgery. These ﬁndings support
the role of chronic irritation in the etiology of verrucous
carcinoma, as discussed by Aydogan et al. [23].
Because of the lack of cases described at this anatomic
site, prognostic information on adjuvant radiation after
surgery is limited. Of the 12 cases described in the litera-
ture in which information regarding patient outcome is
available, the longest recorded survival is in patients trea-
ted with surgery alone; however, this may be due to an
earlier stage of disease and/or more aggressive surgical
treatment. As described above, Edelstein et al. [19] dem-
onstrate a period of survival of 4–10 years in three of ﬁve
of these patients. Although patients treated with adjuvant
radiotherapy and/or chemotherapy did not have compara-
ble survival, this difference could be due to more advanced
disease at presentation.
In the presented case, radical resection of the tumor was
not followed by radiation, as clear margins were achieved
at surgery. In more typical variants of squamous cell car-
cinoma of the temporal bone, adjuvant radiation therapy
has been advocated in an attempt to increase local control
rates [41]. However, studies indicate a high rate of recur-
rence for advanced lesions despite the use of adjuvant
radiotherapy, and the 5-year survival remains poor [42].
Although radiation is not as successful in treatment of
verrucous carcinoma of the larynx as ordinary invasive
squamous cell carcinoma, it has been shown to be very
effective when used for laryngeal preservation and in sur-
gical salvage after surgery with positive margins [36].
Extrapolating from these data, it is reasonable to use
adjuvant radiation for temporal bone verrucous carcinoma
in cases with gross or microscopic positive margins.
Conclusion
Until further data are available on therapeutic outcomes of
verrucous carcinoma of the temporal bone, aggressive
surgery will remain the mainstay of treatment. Although
adjuvant radiation does not increase the risk of recurrence
or dedifferentiation, its efﬁcacy in the treatment of verru-
cous carcinoma of the temporal bone has not been clearly
demonstrated. In view of treatment strategies for verrucous
carcinoma at different anatomic sites and for ordinary
squamous cell carcinoma of the temporal bone, the treating
physician may decide to use radiation in cases of temporal
bone verrucous carcinoma with positive surgical margins.
Novel treatment strategies have also been proposed, such
as the use of palliative radiation in advanced cases, given
the signiﬁcant morbidity of surgery and universally poor
outcomes [16].
Conﬂict of interest statement None.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Kraus FT, Perezmesa C (1966) Verrucous carcinoma: clinical and
pathologic study of 105 cases involving oral cavity, larynx and
genitalia. Cancer 19:26–38
2. Fonts EA, Greenlaw RH, Rush BF, Rovin S (1969) Verrucous
squamous cell carcinoma of the oral cavity. Cancer 23:152–160
3. Ferlito A, Recher G (1980) Ackerman’s tumor (verrucous car-
cinoma) of the larynx: a clinicopathologic study of 77 cases.
Cancer 46:1617–1630
4. McCoy JM, Waldron CA (1981) Verrucous carcinoma of the oral
cavity. A review of forty-nine cases. Oral Surg Oral Med Oral
Pathol 52:623–629
5. Batsakis JG, Hybels R, Crissman JD, Rice DH (1982) The
pathology of head and neck tumors: verrucous carcinoma. Head
Neck Surg 5:29–38
6. McDonald JS, Crissman JD, Gluckman JL (1982) Verrucous
carcinoma of the oral cavity. Head Neck Surg 5:22–28
1930 Eur Arch Otorhinolaryngol (2010) 267:1927–1931
1237. Medina JE, Dichtel W, Luna MA (1984) Verrucous-squamous
carcinomas of the oral cavity. A clinicopathologic study of 104
cases. Arch Otolaryngol 110:437–440
8. Rajendran R, Varghese I, Sugathan CK, Vijayakumar T (1988)
Ackerman’s tumour (verrucous carcinoma) of the oral cavity: a
clinico-epidemiologic study of 426 cases. Aust Dent J 33:295–
298
9. Strojan P, Smid L, Cizmarevic B, Zagar T, Auersperg M (2006)
Verrucous carcinoma of the larynx: determining the best treat-
ment option. Eur J Surg Oncol 32:984–988
10. Yiotakis J, Vamvakidis T, Iakovou E, Manolopoulos L (2009)
Aggressive verrucous carcinoma of the paranasal sinuses invad-
ing the orbit: case report and literature review. J Laryngol Otol
123(11):e23
11. Pattee SF, Bordeaux J, Mahalingam M, Nitzan YB, Maloney ME
(2007) Verrucous carcinoma of the scalp. J Am Acad Dermatol
56(3):506–507
12. Jahn AF, Walter JB, Farkashidy J (1980) Verrucous carcinoma of
the nasopharynx. A clinicopathologic case report. J Otolaryngol
9:84–89
13. Minielly JA, Harrison EG, Fontana RS, Payne WS (1967) Ver-
rucous squamous cell carcinoma of the esophagus. Cancer
20:2078–2087
14. Chute DJ, Stelow EB (2010) Cytology of head and neck squa-
mous cell carcinoma variants. Diagn Cytopathol 38(1):65–80
15. Walvekar RR, Chaukar DA, Deshpande MS, Pai PS, Chaturvedi
P, Kakade A, Kane SV, D’Cruz AK (2009) Verrucous carcinoma
of the oral cavity: a clinical and pathological study of 101 cases.
Oral Oncol 45(1):47–51
16. Pleat JM, Bradley M, Orlando A, Rigby H (2004) Verrucous
carcinoma of the temporal bone: a wolf clothed in wool. Skull
Base 14(1):39–46
17. Woodson GE, Jurco S, Alford BR, McGavaran MH (1981)
Verrucous carcinoma of the middle ear. Arch Otolaryngol
107:63–65
18. Proops DW, Hawke WM, van Nostrand AWP, Harwood AR,
Lunan M (1984) Verrucous carcinoma of the ear. Ann Otol
Rhinol Laryngol 93:385–388
19. Edelstein DR, Smouha E, Sacks SH, Biller HF, Kaneko M,
Parisier SC (1986) Verrucous carcinoma of the temporal bone.
Ann Otol Rhinol Laryngol 95:447–453
20. Diengdoh JV, Leeming RD, Shaw MD (1990) Verrucous carci-
noma of the base of the skull. Br J Neurosurg 4:73–76
21. Farrell ML, Dowe AC (1995) Verrucous carcinoma of the tem-
poral bone. Aust N Z J Surg 65:214–216
22. Hagiwara H, Kanazawa T, Ishikawa K, Fujii T, Kitamura K,
Noguchi Y, Iino Y (2000) Invasive verrucous carcinoma: a
temporal bone histopathology report. Auris Nasus Larynx
27:179–183
23. Aydogan LB, Ozdemir S, Gumurdula D (2008) Verrucous car-
cinoma of the temporal bone. Am J Otolaryngol 29(1):69–71
24. Kletzker GR, Smith PG, McIntire LD, Leonetti JP (1995) Pre-
sentation and management of uncommon lesions of the middle
ear. Am J Otol 16(5):634–642
25. Koch BB, Trask DK, Hoffman HT, Karnell LH, Robinson RA,
Zhen W, Menck HR (2001) National survey of head and neck
verrucous carcinoma: patterns of presentation, care, and outcome.
Cancer 92(1):110–120
26. Orvidas LJ, Olsen KD, Lewis JE, Suman VJ (1998) Verrucous
carcinoma of the larynx: a review of 53 patients. Head Neck
20:197–203
27. Pindborg JJ, Reichart PA, Smith CJ, van der Wall I (1997) His-
tological typing of cancer and precancer of the oral mucosa, 2nd
edn. Springer, Berlin, pp 10–16
28. McCoy JM, Waldron CA (1981) Verrucous carcinoma of the oral
cavity: a review of forty-nine cases. Oral Surg Oral Med Oral
Pathol 52(6):623–629
29. Thompson LD (1997) Diagnostically challenging lesions in head
and neck pathology. Eur Arch Otorhinolaryngol 254(8):357–366
30. Bouquot JE (1999) Oral verrucous carcinoma. Incidence in two
US populations. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod 86(3):318–324
31. Ferlito A, Rinaldo A, Mannara GM (1998) Is primary radio-
therapy an appropriate option for the treatment of verrucous
carcinoma of the head and neck? J Laryngol Otol 112:132–139
32. Hagen P, Lyons GD, Haindel C (1993) Verrucous carcinoma of
the larynx: role of human papillomavirus, radiation, and surgery.
Laryngoscope 103:253–257
33. Edstrom S, Johansson SL, Lindstrom J, Sandin I (1987) Verru-
cous squamous cell carcinoma of the larynx: evidence for
increased metastatic potential after irradiation. Otolaryngol Head
Neck Surg 97:381–384
34. Lundgren JA, van Nostrand AW, Harwood AR, Cullen RJ, Bryce
DP (1986) Verrucous carcinoma (Ackerman’s tumor) of the lar-
ynx: diagnostic and therapeutic considerations. Head Neck Surg
9:19–26
35. Rider WD (1975) Toronto experience of verrucous carcinoma of
the larynx. Can J Otolaryngol 4:278–279
36. O’Sullivan B, Warde P, Keane T, Irish H, Cummings B, Payne D
(1995) Outcome following radiotherapy in verrucous carcinoma
of the larynx. Int J Radiat Oncol Biol Phys 32:611–617
37. Huang SH, Lockwood G, Irish J, Ringash J, Cummings B,
Waldron J, Kim J, Dawson LA, Bayley A, Hope A, O’Sullivan B
(2009) Truths and myths about radiotherapy for verrucous car-
cinoma of larynx. Int J Radiat Oncol Biol Phys 73(4):1110–1115
38. Maurizi M, Cadoni G, Ottaviani F, Rabitti C, Almadori G (1996)
Verrucous squamous cell carcinoma of the larynx: diagnostic and
therapeutic considerations. Eur Arch Otorhinolaryngol 253:130–
135
39. Tharp ME 2nd, Shidnia H (1995) Radiotherapy in the treatment
of verrucous carcinoma of the head and neck. Laryngoscope
105(4 Pt 1):391–396
40. McCaffrey TV, Witte M, Ferguson MT (1998) Verrucous carci-
noma of the larynx. Ann Otol Rhinol Laryngol 107(5 Part
1):391–395
41. Cristalli G, Manciocco V, Pichi B, Marucci L, Arcangeli G,
Telera S, Spriano G (2009) Treatment and outcome of advanced
external auditory canal and middle ear squamous cell carcinoma.
J Craniofac Surg 20(3):816–821
42. Kunst H, Lavieille JP, Marres H (2008) Squamous cell carcinoma
of the temporal bone: results and management. Otol Neurotol
29(4):549–552
Eur Arch Otorhinolaryngol (2010) 267:1927–1931 1931
123